Rtw Investments, LP Argenx Se Transaction History

Rtw Investments, LP

$6.13 Billion
Q4 2024

A detailed history of Rtw Investments, LP transactions in Argenx Se stock. As of the latest transaction made, Rtw Investments, LP holds 673,497 shares of ARGX stock, worth $434 Million. This represents 6.76% of its overall portfolio holdings.

Number of Shares

673,497

Previous 654,430 2.91%

Holding current value

$434 Million

Previous $355 Million 16.7%

% of portfolio

6.76%

Previous 5.66%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$520.52 - $638.33 $9.92 Million - $12.2 Million	19,067 Added 2.91%	673,497 $414 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $4.54 Million - $5.76 Million	-12,765 Reduced 1.91%	654,430 $281 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $54.2 Million - $81 Million	160,000 Added 31.55%	667,195 $254 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $9.23 Million - $13.7 Million	25,000 Added 5.18%	507,195 $249 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $5.13 Million - $6.03 Million	15,000 Added 3.21%	482,195 $183 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $8.43 Million - $9.72 Million	24,560 Added 5.55%	467,195 $165 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $28.5 Million - $40 Million	105,657 Added 31.35%	442,635 $168 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $4.97 Million - $6.86 Million	19,531 Added 6.15%	336,978 $106 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $48.2 Million - $62.5 Million	177,136 Added 126.25%	317,447 $111 Million
Q3 2021 Nov 15, 2021	BUY	$295.0 - $350.58 $32 Million - $38.1 Million	108,559 Added 341.9%	140,311 $42.4 Million
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $25,155 - $38,753	236 Added 0.75%	31,752 $5.1 Million
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $7,705 - $10,234	68 Added 0.22%	31,516 $3.59 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $84,410 - $103,919	734 Added 2.39%	31,448 $4.45 Million
Q1 2019 May 15, 2019	BUY	$98.85 - $134.59 $191,472 - $260,700	1,937 Added 6.73%	30,714 $3.83 Million
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $122,770 - $211,293	1,924 Added 7.16%	28,777 $2.77 Million
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $97,697 - $125,039	1,294 Added 5.06%	26,853 $2.04 Million
Q2 2018 Aug 14, 2018	BUY	$74.84 - $100.16 $7,633 - $10,216	102 Added 0.4%	25,559 $2.12 Million
Q1 2018 May 14, 2018	BUY	$56.95 - $85.19 $11,219 - $16,782	197 Added 0.78%	25,457 $2.05 Million
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $7,989 - $22,500	354 Added 1.42%	25,260 $1.6 Million
Q3 2017 Nov 14, 2017	BUY	$19.81 - $22.61 $493,387 - $563,124	24,906	24,906 $563,000

Others Institutions Holding ARGX

# of Institutions

432

Shares Held

29.2M

Call Options Held

390K

Put Options Held

272K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.7B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account

Rtw Investments, LP Argenx Se Transaction History